Rheumatology/Arthritis Market Research Reports & Industry Analysis
Some evidence suggests that excessive immune responses may be due to glucocorticoid resistance in target tissues. For example, the number of glucocorticoid receptors in circulating leukocytes is decreased 50% in patients with RA. This decrease in receptors would prevent adequate suppression of leukocyte activity and could further enhance inflammation.Rheumatologists remain the most up-to-date health professionals in autoimmune disease treatment. Early intervention has been noted by nearly all in the field as the single most important factor in treatments and continued quality of life. New advancements in risk factors, diagnosis, and therapies have made it possible for rheumatologist to treat these conditions successfully with the best possible outcomes.
Successful treatment of autoimmune diseases have resulted from a growing array of therapies available to specialists. Symptomatic treatments have traditionally been used for patients with rheumatoid arthritis, lupus and other autoimmune disorders. While these treatments are still used regularly, new disease-modifying therapies have produced the most impressive results in treating these diseases. Additionally, combination therapies continue to grow in preference and offer exciting results in disease management.
Rheumatology/Arthritis Industry Research & Market Reports
-
Corticosteroids Therapy
... at a CAGR of 4.6% over the analysis period 2023-2030. Glucocorticoids, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
Global Musculoskeletal Drugs Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Rheumatology Therapeutics
... CAGR of 3.1% over the analysis period 2023-2030. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$51.3 Billion by the end ... Read More
-
Musculoskeletal Disorders Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 6.5% during 2025-2034. This report on global musculoskeletal disorders drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... projected to to expand to a value of USD 3.02 billion in 2030 from USD 1.40 billion in 2024, with a significant CAGR of 13.6%. The autoinjector finished formulations market is projected to surge to ... Read More
-
Bone Densitometer Market Report by Device Type (Axial Bone Densitometers, Peripheral Bone Densitometers), Technology (Dual-Energy X-Ray Absorptiometry (DXA), Single X-Ray Absorptiometry (SXA), Radiographic Absorptiometry (RA), Quantitative Computed Tomography (QCT), and Others), Application (Osteoporosis and Osteopenia Diagnosis, Cystic Fibrosis Diagnosis, Body Composition Measurement, Rheumatoid Arthritis Diagnosis, and Others), End-User (Hospitals & Specialty Clinics, Diagnostics and Imaging Centers, and Others), and Region 2024-2032
... Diagnosis, Cystic Fibrosis Diagnosis, Body Composition Measurement, Rheumatoid Arthritis Diagnosis, and Others), End-User (Hospitals & Specialty Clinics, Diagnostics and Imaging Centers, and Others), and Region 2024-2032 The global bone densitometer market size reached US$ 307.6 ... Read More
-
TNF Inhibitors
... at a CAGR of 6.5% over the analysis period 2023-2030. Rheumatoid Arthritis Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$22.7 Billion by the end ... Read More
-
Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030
... projected to reach USD 13.1 billion by 2030 from USD 7.1 billion in 2024, at a CAGR of 10.8% during the forecast period. The prefilled syringes market has had strong growth due to a number ... Read More
-
Global Log Management Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Rheumatoid Arthritis Diagnostic Devices Market 2024-2028
... 4.51% during the forecast period. The report on the rheumatoid arthritis diagnostic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... reach US$944.9 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and ... Read More
-
Rheumatoid Arthritis Therapeutics
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Pharmaceuticals Molecule, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$28.0 Billion by ... Read More
-
Hydroxychloroquine Market Size, Trends, Analysis, and Outlook By Product (Tablet, Active Pharmaceutical Ingredients), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Drug Store), By Disease (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Coronavirus, Others), by Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Hydroxychloroquine market size is poised to register a 7.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The Hydroxychloroquine market study ... Read More
-
Juvenile Rheumatoid Arthritis – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Juvenile Rheumatoid Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Juvenile Rheumatoid Arthritis market report provides current ... Read More
-
Global Autoinjectors Market Size study & Forecast, by Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others), Type (Disposable Autoinjectors and Reusable Autoinjectors), End User (Home Care Settings, Hospital and Clinics, and Others), and Regional Analysis, 2023-2030
... 2023-2030 Global Autoinjectors Market is valued approximately USD 8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.05% over the forecast period 2023-2030. Autoinjectors are medical devices ... Read More
-
Injectable Cytotoxic Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 18.29 billion in 2023, and the market is now projected to grow from USD 19.03 billion in 2024 to USD 30.85 billion by 2032, exhibiting a CAGR of 6.2% during the forecast ... Read More
-
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Rheumatoid Arthritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Biologic Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030 The global Biologic Therapeutics market size is poised to register 7.8% growth (CAGR) from 2024 ... Read More
-
Tumor Necrosis Factor Inhibitor Drugs Market Size, Trends, Analysis, and Outlook By Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Tumor Necrosis Factor Inhibitor Drugs market size is poised to register 1.73% growth ... Read More
-
Rheumatoid Arthritis Therapeutics Market Size, Trends, Analysis, and Outlook By Pharmaceuticals Molecule (NSAIDs, Analgesics, DMARDs, Glucocorticoids), By Biopharmaceuticals Molecule (Biologics, Biosimilars), By Sales Channel (Prescription, Over-the-Counter), by Region, Country, Segment, and Companies, 2024-2030
... Rheumatoid Arthritis Therapeutics market size is poised to register 4.95% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Rheumatoid Arthritis Therapeutics market ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Musculoskeletal Disorders
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
